Browsing by Author "Gumus, Mahmut"
Now showing items 1-15 of 15
-
A comparison of metacognitive factors among patients with cancer and the control group
MUTLU, HASAN HÜSEYİN; Bilican, F. Isil; Mutlu, Hacer Hicran; Gumus, Mahmut (2018-04-01)Objective: Research examining the relationship between metacognitions and cancer has only recently begun to emerge. This study attempted to compare the metacognitions of the patients with and without cancer. The effects ... -
Cemiplimab monotherapy as first-line (1L) treatment of patients with brain metastases from advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) >= 50%: EMPOWER-Lung 1 subgroup analysis.
Gladkov, Oleg; Rietschel, Petra; Gullo, Giuseppe; Bentsion, Dmitry; Clingan, Philip R.; Lowy, Israel; Seebach, Frank A.; Lee, Sue; Pouliot, Jean-Francois; McGinniss, Jennifer; Rizvi, Naiyer A.; Sriuranpong, Virote; Ozguroglu, Mustafa; Sezer, Ahmet; Kilickap, Saadettin; Gumus, Mahmut; Bondarenko, Igor; Gogishvili, Miranda; Turk, Haci M.; Cicin, Irfan (2021-05-01) -
COULD PRETREATMENT PET-CT STANDART UPTAKE VALUES HAVE A ROLE IN THE RESPONSE TO TREATMENT AND THE SURVIVAL IN PATIENTS WITH SMALL CELL LUNG CANCER?
Aydin, Kubra; Odabas, Hatice; Seker, Mesut; Korkmaz, Taner; Yasar, Nurgul; Sener, Nur; Aydin, Dincer; Ercelep, Ozlem; Yuksel, Sinemis; Mert, Aslihan G.; Aliustaoglu, Mehmet; Mayadagli, Alpaslan; Dane, Faysal; Gumus, Mahmut (2013-11-01) -
DETERMINATION OF PARAMETERS AFFECTING THE USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE IN CANCER PATIENTS AND DETECTION OF PREVALENCE OF USE
Mayadagli, Alpaslan; Aksu, Atinc; Goksel, Fatih; Gocen, Erkan; KARAHACIOĞLU, ERAY; Gumus, Mahmut; Pak, Yucel (2011-01-01)This study was conducted to find out the frequency of complementary and alternative medicine (CAM) use that could lead to troubles in patient health and in applied standard therapy protocols when used improperly, which ... -
Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study
Oven, Bala B.; Demirtas, Derya; Erdemoglu, Engin; HACIBEKİROĞLU, İLHAN; Cakir, Emre; Tanrikulu, Eda; Coban, Ezgi; Ozcelik, Melike; Celik, Sinemis; Teker, Fatih; AKSOY, ASUDE; Firat, Sedat T.; Tekin, Omer; Kalkan, Ziya; Turken, Orhan; Dane, Faysal; Bilici, Ahmet; Isikdogan, Abdurrahman; ŞEKER, Mesut; TÜRK, HACI MEHMET; Gumus, Mahmut; YASİN, Ayşe İrem; Aydin, Sabin Goktas; SÜMBÜL, BİLGE; KORAL, LOKMAN; ŞİMŞEK, MELİH; Geredeli, Caglayan; Ozturk, Akin; Perkin, Perihan (2022-01-01)Aim: To compare the seropositivity rate of cancer patients with non-cancer controls after inactive SARS-CoV-2 vaccination (CoronaVac) and evaluate the factors affecting seropositivity. Method: Spike IgG antibodies against ... -
Frequency of EGFR Mutation in Nsclc and Its Relationship with Clinicopathological Features: A Multicenter Asmo Trial
Yuksel, Sinemis; Kodaz, Hilmi; Yildiz, Ibrahim; Odabasi, Hatice; Ocak, Ayse; Bayoglu, Ibrahim V.; Hacibekiroglu, Ilhan; Ercelep, Ozlem; Ekinci, Ahmet S.; ERDOĞAN, BÜLENT; Mert, Aslihan G.; Karaca, Halit; Salman, Tarik; Menekse, Serkan; Gumusay, Ozge; Ustaalioglu, Basak O.; Aldemir, Mehmet N.; Geredeli, Caglayan; Baykara, Meltem; UYSAL, MÜKREMİN; Sevinc, Alper; AKSOY, ASUDE; Ulas, Arife; İNANÇ, MEVLÜDE; Tanriverdi, Ozgur; Avci, Nilufer; Turan, Nedim; Aliustaoglu, Mehmet; Gumus, Mahmut (2015-09-01) -
Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology
Odabas, Hatice; Ulas, Arife; Aydin, Kubra; İNANÇ, MEVLÜDE; Aksoy, Asude; Yazilitas, Dogan; Turkeli, Mehmet; Yuksel, Sinemis; Inal, Ali; Ekinci, Ahmet S.; Sevinc, Alper; Demirci, Nebi S.; UYSAL, MÜKREMİN; Alkis, Necati; Dane, Faysal; Aliustaoglu, Mehmet; Gumus, Mahmut (2015-12-01)Patients with advanced non-small cell lung cancer (NSCLC) generally require second-line treatment although their prognosis is poor. In this multicenter study, we aimed to detect the characteristics related to patients and ... -
Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
Eser, Mehmet; Kement, Metin; Balin, Salim; Coskun, Cihan; KEFELİ, UMUT; Gumus, Mahmut; Altuntas, Yunus Emre; Kurt, Necmi; Mayadagli, Alpaslan (2012-08-01)Background: The purpose of this study was to investigate plasma levels of thrombin activatable fibrinolysis inhibitor (TAFI) and TAFI-s relationship with coagulation markers (prothrombin fragment 1 + 2) in gastric cancer patients. -
Patient-reported symptoms, functioning, and quality of life (QoL) in patients treated with cemiplimab monotherapy for first-line treatment of advanced NSCLC with PD-L1 >= 50%: Results from EMPOWER-Lung 1 study.
Gumus, Mahmut; Mastey, Vera; Harnett, James; Sezer, Ahmet; Chen, Chieh-I; Cicin, Irfan; Turk, Haci M.; Gogishvili, Miranda; Ozguroglu, Mustafa; Bondarenko, Igor; Kilickap, Saadettin; Ivanescu, Cristina; Naumann, Ulrike; Reaney, Matthew; Konidaris, Gerasimos; Sasane, Medha; Brady, Keri; Li, Siyu; Gullo, Giuseppe; Rietschel, Petra (2021-05-01) -
Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)
Inal, Ali; Kodaz, Hilmi; Odabas, Hatice; Duran, Ayse Ocak; Seker, Mehmet Metin; Inanc, Mevlide; ELKIRAN, EMİN TAMER; Gunaydin, Yusuf; Menekse, Serkan; Topcu, Turkan Ozturk; Urakci, Zuhat; Tastekin, Didem; BİLİCİ, Mehmet; Cihan, Sener; Geredeli, Caglayan; SEZER, EMEL; Uncu, Dogan; Arpaci, Erkan; Ozturk, Banu; Bal, Oznur; UYSAL, MÜKREMİN; TANRIVERDİ, ÖZGÜR; Gumus, Mahmut; Ustaalioglu, Bala Basak Oven; Suner, Ali; Cokmert, Suna; Hacibekiroglu, Ilhan; Aydin, Kubra; Isikdogan, Abdurrahman (2018-04-01)Purpose: Almost half of all patients diagnosed with non-small cell lung cancer (NSCLC) have distant metastases at presentation. One-third of patients with NSCLC will have brain metastases. Without effective treatment, the ... -
Prognostic significance of protein kinase B/Akt pathway in patients with non-small cell lung cancer
Mayadagli, Alpaslan; Gul, Sule Karabulut; Bilici, Ahmet; Oruc, Ahmet Fatih; Kocak, Mihriban; Ozkan, Alper; Aksu, Atinc; Barisik, Nagehan Ozdemir; Gumus, Mahmut (2014-01-01)Purpose: Akt, also known as protein kinase B (PKB), is an intracellular signal transduction protein activated by growth hormones. PKB/Akt is frequently activated in a variety of cancer types, but its role in the development ... -
Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.
Turk, Haci M.; Gumus, Mahmut; Cevik, Duygu; Yalcin, Suayib; Bilir, Cemil; Bilici, Ahmet; Dane, Faysal; Simsek, Eda Tanrikulu; Alacacioglu, Ahmet; Sendur, Mehmet Nahit; Artac, Mehmet; Karaca, Mustafa; Kefeli, Umut; Arslan, Cagatay; Yildirim, Mahmut Emre; Isikdogan, Abdurrahman; Karadurmus, Nuri; Karabulut, Bulent; Cubukcu, Erdem; Cicin, Irfan (2021-05-01) -
Results of observational study to determine K-ras mutation rates in 2458 patients with metastatic colorectal cancer in Turkey (TURKRAS Study).
Gumus, Mahmut; Dane, Faysal; Karabulut, Bulent; Uygun, Kazim; Aydin, Kubra; Orhan, Bulent; Oksuzoglu, Berna; Tarhan, Oktay; Buyukberber, Suleyman; Okutur, Kerem; Yucel, Idris; Zengin, Nurullah; Isikdogan, Abdurrahman; Unek, Tugba; Yavuz, Sinan; Harputluoglu, Hakan; Ozen, Ridvan Seckin (2015-05-01) -
Tissue and Serum Adiponectin Levels in Patients with Gastric Cancer: Are there any Correlations between Adiponectin Levels and Histopathological Variables?
ŞEKER, MESUT; Bilici, Ahmet; Güler, Derya Öztaş; Ustaalioglu, Bala Başak; Gozu, Hulya; Erkal, Fatih Yavuz; Sönmez, BERKANT; Karaduman, Mustafa; Kefeli, Umut; Yıldırım, Emre; Salepci, Taflan; Gumus, Mahmut (2011-09-01)Background/Aims: Adiponectin is secreted from adipose tissue and is characterized by hyperinsulinemia, which is related with obesity. Adiponectin levels are significantly lower in gastric cancer patients than in healthy ... -
What are the differences between young (25 years) and adults (> 25 years) colorectal cancer (CRC)? An Anatolian Society of Medical Oncology Study.
Kaplan, Muhammet Ali; Urakci, Zuhat; Gumus, Mahmut; Arslan, Ulku Yalcintas; Geredeli, Caglayan; Ozdemir, Nuriye; Koca, Dogan; Oruc, Zeynep; Uysal, Mukremin; Dane, Faysal; Sevinc, Alper; Seker, Mehmet Metin; Aksoy, Asude; Kucukoner, Mehmet; Pilanci, Kezban Nur; Topcu, Turkan Ozturk; Karaagac, Mustafa; Yildiz, Ramazan; Isikdogan, Abdurrahman (2015-05-01)
